Terumo Corporation · TSE:4543

Terumo — Q1 FYE 3/2012 Earnings Presentation

21 slides from Terumo's earnings presentation, Jul 28, 2011

  1. Slide 1: Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2012

    Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2012 Terumo Corporation July 28, 2011

  2. Slide 2: Consolidated Q1 Results

    Consolidated Q1 Results Marked an excellent start for dramatic growth (billions of yen) Q1 Q1 YoY% Mar. 2011 Mar. 2012 (*) Net Sales 81.2 95.6 +18% Gross Profit 42.3 (52.1%) 50.9 (53.2%) +20% SG&A Expenses 26.4 (32.5%) 33.5 (35.0%) +27% Operating Income 15.9 (19.6%) 17.4 (18.2%) +9% (Excl. Amortizat

  3. Slide 3: Consolidated Q1 Results (Pro-forma comparison)

    Consolidated Q1 Results (Pro-forma comparison) Increase both in sales & income even at Pro-forma comparison (billions of yen) Corresponding Excluding Q1 period of last yr Mar. 2012 YoY% Foreign Pro-forma basis *1 Exchange Net Sales 93.1 95.6 +3% +7% Gross Profit 49.7(53.4%) 50.7(53.0%) +2% +8% SG&A

  4. Slide 4: Q1 Results of BCT Stand Alone

    Q1 Results of BCT Stand Alone Favorable start after acquisition (billions of yen) Q1 YoY% Mar. 2012 (Excluding Foreign Exchange) Net Sales 11.9 +17% Gross Profit 7.5 (62.4%) +19% SG&A Expenses 4.6 (38.5%) +25% Operating Income 2.9 (23.9%) +10% Ordinary Income 2.9 (24.4%) Net Income 1.8 (15.3%) 2011/

  5. Slide 5: Q1 Results of Existing Business

    Excluding BCT & Harvest Q1 Results of Existing Business Steady increase both in sales & income (billions of yen) Q1 Q1 Excluding YoY% Foreign Mar. 2011 Mar. 2012 Exchange Net Sales 81.2 83.4 +3% +6% Gross Profit 42.3(52.1%) 43.0(51.6%) +2% +6% SG&A Expenses 26.4(32.5%) 26.0(31.3%) -1% +2% Operating

  6. Slide 6: Net Sales (by Region)

    Excluding BCT & Harvest Net Sales (by Region) (billions of yen) Consolidated：+3%(+6%) Q1 Q1 Mar. 2011 Mar. 2012 ( )Excluding Foreign Exchange Japan Outside of Japan +4% +2% 14.0 +11% (+8%) Europe (+12%) 15.6 -10% 14.8 Americas (+2%) 13.3 42.5 44.3 2.4 38.3 39.1 +18% China (+32%) 2.8 Asia +3% 7.2 & o

  7. Slide 7: Net Sales (by Business Segment)

    Excluding BCT & Harvest Net Sales (by Business Segment) (billions of yen) +9% Q1 Q1 -2% (+14%) Mar. 2011 Mar. 2012 (-1%) -5% ( )Excluding Foreign Exchange (-2%) 37.1 36.5 36.5 39.6 +41% 6.5 6.1 (+43%) 1.1 0.8 General Cardiac & Blood Consumer Hospital Vascular Management Healthcare 2011/7/28 ©Terumo

  8. Slide 8: Gross Profit Variance Analysis

    Excluding BCT & Harvest Gross Profit Variance Analysis 0．2 Volume 0．7 0．4 Shift to Highly Foreign 0．3 Profitable Exchange Products Prices 0．1 52.1% Others 51.6% Q1 Q1 Average Q1 Q1 Mar. 2011 Exchange Rate Mar. 2011 Mar. 2012 Mar. 2012 US$: 92yen 82yen EUR: 117yen 117yen 2011/7/28 ©Terumo Corporation

  9. Slide 9: SG&A Expenses

    Excluding BCT & Harvest SG&A Expenses (billions of yen) Q1 Mar. 2011 Q1 Mar. 2012 YoY YoY% Salaries & Wages 9.8 9.8 +0 +1% Sales Promotion 2.6 2.6 -0 -1% Logistical Costs 2.3 2.5 +2 +7% Depreciation & Amortization 1.1 1.0 -1 -7% Others 5.7 5.8 +1 +3% General Administrative Total 21.5(26.5%) 21.7(26.

  10. Slide 10: Consolidated B/S after BCT Acquisition

    Consolidated B/S after BCT Acquisition „ Purchase Price Allocation for BCT „ Terumo group B/S after consolidation End of June, 2011 (Actual currency rate) Purchase price 210.0 billion yen Liabilities Working capital 5.6 355.6 Asset Acquisition price 215.6 B/S of BCT 427.8 Debt Stand Alone BCT assets

  11. Slide 11: Forecast for Mar 31, 2012

    Forecast for Mar 31, 2012 Double-digit growth both in sales & income (billions of yen) Revised Forecast Original Forecast Existing Consolidated YoY% YoY% (Excl. BCT & Harvest) Businesses (Incl. BCT & Harvest) Net Sales 332.0 340.5 +4% 390.0 +19% Operating Income 65.0(19.6%) 67.0(19.7%) +7% 67.0(17.2

  12. Slide 12: Topics

    Topics „Nobori™ DES: Launched in Japan „Expected New Products Launch 2011/7/28 ©Terumo Corporation 12/21

  13. Slide 13: Nobori Targeting Sales of 20 billion yen

    Nobori™ Targeting Sales of 20 billion yen Nobori™ Sales Performance Launched in JP (billions of yen) May 5, 2011 20 Global cumulative sales achieved Japan 10 billion yen 10 Outside of Japan 0 Mar. 2009 Mar. 2010 Mar. 2011 Mar. 2012 (Forecast) Gained 30% JP mkt share (value base) in 2 mos after the l

  14. Slide 14: New Products Launch To Be Doubled

    New Products Launch New Products Launch To Be Doubled <Japan> ¾ DuraHeart™ Left Ventricular Assist System 45 launches ¾ New bare embolization coil for cerebral aneurysm ¾ First-in-JP Glucose Monitor which links to EMR ¾ PG Water™ Rehydrating Water Jelly type ¾ New IV catheter 23 launches <Outside of

  15. Slide 15: Establishing a Holding Company in China

    Establishing a Holding Company in China TERUMO(China)Holdings Co., Ltd.： Approved to establish in Beijing (Jul 18) ¾ Strengthen business base, incl. local development, production, and sales ¾ Establish additional 4 sales offices in addition to current 8 sales offices Changchung Factory TERUMO(China)

  16. Slide 16: Reference

    Reference 2011/7/28 ©Terumo Corporation 16/21

  17. Slide 17: Impact of BCT & Harvest to Consolidated Operating Income

    Impact of BCT & Harvest to Consolidated Operating Income (billions of yen) Forecast Mar. 2012 Net Sales (BCT & Harvest) 49.5 Operating Income 9.2 (BCT & Harvest) Amortization of goodwill -6.1 Amortization of -3.1 newly accrued intangible assets Impact to 0 consolidated Operating Income 2011/7/28 ©Te

  18. Slide 18: Q1 Results To 1st Half Forecast

    Q1 Results To 1st Half Forecast (billions of yen) 1H Forecast Q1 Results Progress Net Sales 191.0 95.6 50% Operating Income 32.7 (17.1%) 17.4 (18.2%) 53% Ordinary Income 31.5 (16.5%) 16.9 (17.6%) 54% Net Income 18.5 (9.7%) 9.8 (10.2%) 53% Average exchange rates (US$) 80 yen 82 yen (EUR) 113 yen 117

  19. Slide 19: Gross Profit, SG&A Expenses, Operating Income

    Excluding BCT & Harvest Gross Profit, SG&A Expenses, Operating Income (%) Gross Profit 52.1 52.3 51.7 52.0 51.6 SG&A Expenses 32.5 32.1 32.5 34.7 31.3 Operating Income 19.6 20.3 19.2 17.3 20.3 Q1 Q2 Q3 Q4 Q1 Mar. 2011 Mar. 2012 (Quarterly: 3 months) 2011/7/28 ©Terumo Corporation 19/21

  20. Slide 20: Changes of Quarterly Average Exchange Rates

    Changes of Quarterly Average Exchange Rates yen EUR (Mar. 2011) 120 117 EUR (Mar. 2012) 100 US$ (Mar. 2011) US$ (Mar. 2012) 80 82 Q1 Q2 Q3 Q4 (Quarterly: 3 months) 2011/7/28 ©Terumo Corporation 20/21

  21. Slide 21: IR Contact

    IR Contact TERUMO Corporation Corporate Communication (IR) Dept. E-mail: [email protected] Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since these are forecasts on projections made by Terumo

Terumo — Q1 FYE 3/2012 Earnings Presentation on 6ix